Read This First
This page is not built on clinical evidence. Cost and access are commercial and legal facts, not scientific findings. They come from the regulatory record in Russia, where selank is a medicine, and in the United States, where it is not.
Selank has a price in Russia, where it is sold as nasal drops on the ordinary terms of a registered pharmaceutical. It has no price, no prescription route and no insurance pathway anywhere else, because no other regulator has approved it, and it has not been before the FDA's advisory committee at all.1
This page publishes no prices. What follows is what determines the money.
Why There Is No Single Price
Two Markets That Do Not Touch
In Russia, selank is priced like a registered nasal drop, made by a licensed manufacturer for its registered use in anxiety. Outside Russia, three different things are sold under its name: the Russian product exported beyond its lawful market, vendor-made nasal sprays, and injectable powder for a route no study has used. Each has a different price, and none is a verified product.
What a Price Normally Represents
For an approved medicine, a price sits on top of a known quantity of a known substance, made to a validated standard, for a stated indication, with a documented effect. In Russia, selank has those things for anxiety, on the basis of open-label trials against a benzodiazepine that a non-Russian reader cannot fully examine.2 Outside Russia it has none of them, and the effects it is sold for, focus and "calm without sedation" in healthy people, are not what the Russian registration covers.
Access
Is There a Legal Route in the United States?
No. Selank is not approved, is not a component of an approved drug, and is not on the 503A bulks list. It was placed in the FDA's Category 2 of nominated compounding substances in September 2023 and is now listed as nominated but withdrawn.1 It was not among the peptides considered by the advisory committee in July 2026, so unlike semax there is no pending recommendation.3 There is no clinical trial to join; none is registered.
What About the Semax/Selank Pair?
The two are commonly sold together, and the semax half was recommended by the committee for three neurological conditions.4 Even if the FDA adopts that recommendation, it would cover semax alone, for stroke, migraine and trigeminal neuralgia. A pair product would remain exactly as unlawful to compound as selank is, because a combination takes the legal position of its least-permitted component.
Can the Russian Product Be Imported?
Not lawfully as a rule. Importing an unapproved drug for personal use is prohibited; the FDA's enforcement discretion is limited to serious conditions with no US treatment, a small supply and a US physician's involvement, and an anxiety nasal spray, for which many approved treatments exist, does not meet that. ONPEPS does not advise on customs law. A buyer of imported drops is trusting a retailer for genuineness, storage and formulation; the one injury on file for the related semax drops involved exactly that channel.5
Does Insurance Cover It?
Not outside Russia, and there is nothing to appeal. Payers reimburse approved products for approved indications.
Can HSA or FSA Funds Be Used?
Tax-advantaged health accounts cover qualified medical expenses, which generally requires a legitimate medical purpose and often a provider's documentation. A product that cannot lawfully be dispensed in the United States sits poorly against that. The account holder carries the consequences of a disallowed expense; the question belongs with the plan administrator.
What the Money Buys
Where Does the Spread Between Channels Come From?
| Channel | What is supplied | What the price includes | What it does not |
|---|---|---|---|
| Russian pharmacy, in Russia | Registered nasal drops | A product a regulator has reviewed, for anxiety | Any use beyond that; availability outside Russia |
| Online retailer, imported drops | The Russian product, or something labelled as it | A box and a label | Verification of genuineness; lawful import; recourse |
| US clinic or vendor, nasal spray | Selank powder in a spray device | A consultation, sometimes; a bottle | Any information on whether the device delivers a dose |
| Vendor, injectable powder | Selank for subcutaneous injection | A vial | Any human data by that route; sterility assurance |
| Any channel, semax/selank pair | Two peptides priced as one | A protocol | Any evidence for the combination; attribution of the price to either component |
ONPEPS publishes no prices; read this as reasoning about cost structure rather than a measured breakdown. What the spread never buys outside Russia is a product made to the standard the Russian trials used, delivered by the route and device they used.
The Spending Decision
What Result Is Being Paid For?
Less anxiety without sedation or dependence. That is what the Russian trials report, in open-label comparisons with phenazepam, a benzodiazepine, in 60 and 70 people, published in Russian.26 There is no placebo-controlled trial, no English-language trial, and nothing at all for the focus and cognition uses that drive sales outside Russia.
The mechanism is coherent: inhibition of enkephalin breakdown and altered GABA-related gene expression are both plausible routes to an anxiolytic.7 They are also the opioid and benzodiazepine pathways, and a compound that works through them has not been tested for tolerance or dependence in any design that could find them.
A buyer of selank for calm is paying for a Russian anxiolytic on the strength of trials against a drug that is itself hard to beat on side effects, for a use those trials did not study, delivered by a device nobody has qualified.
What Is the Risk Side of the Ledger?
Probably low for the Russian product used as registered, and unmeasured for everything else. The FDA's entry says it "lacks important information regarding any safety issues raised by selank acetate administered to humans."1 The developers' own laboratory has published on the anticoagulant effects of this peptide family, and the FDA raised a bleeding concern for semax on the same basis.85 For the injectable route there is no safety data at all.
What Should Be Asked Before Paying?
Is this the Russian registered product, a compounded spray, or powder? The answer determines everything else.
Which human study, by this route, measured the outcome you are promising in someone without an anxiety disorder?
For a pair product, what is the price of each component separately, and which study tested them together? The honest answer to the second is none.
Are you aware this compound has never been reviewed by the FDA's advisory committee, and on what legal basis are you supplying it?
Do you ask whether buyers take anticoagulants?
Does anyone here earn commission on product sales?
What Would Change This Page
A Nomination, or a Readable Trial
A nomination to the FDA's advisory committee would produce, at minimum, a regulator's reading of the Russian record and a vote. A placebo-controlled trial published in English would change the evidence position for the first time. Neither is scheduled.
A Note on "It's a Prescription Drug in Russia"
True, and the most common thing said in its favour. The Russian registration covers nasal drops for anxiety, on the basis of trials that have not been independently reviewed. It does not cover cognitive enhancement, it does not cover injection, and it is not a price signal for anything sold outside Russia. ONPEPS treats it as a fact about one regulator, not as evidence.
Related ONPEPS Coverage
Selank library entry: the mechanism, the Russian trials and the regulatory gap
Selank sourcing and quality: the other half of the Moscow pair
FDA peptide news July 2026: the votes, the dissent and what happens next
Sources
US Food and Drug Administration. Category 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Entry for selank acetate (TP-7). Content current as of 22 April 2026. fda.gov
Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22. In Russian; English abstract. pubmed.ncbi.nlm.nih.gov/25176261
US Food and Drug Administration. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. Docket FDA-2025-N-6895. fda.gov
ONPEPS. FDA peptide news July 2026: the only source you need. onpeps.com
US Food and Drug Administration. Semax-related bulk drug substances: FDA presentation to the Pharmacy Compounding Advisory Committee, 24 July 2026. Docket FDA-2025-N-6895. fda.gov
Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, Gushanskaya EV, Chobanu IK, et al. Optimization of the treatment of anxiety disorders with selank. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):33-40. In Russian; English abstract. pubmed.ncbi.nlm.nih.gov/26356395
Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, et al. Semax and selank inhibit the enkephalin-degrading enzymes from human serum. Bioorg Khim. 2001;27(3):180-183. In Russian; English abstract. pubmed.ncbi.nlm.nih.gov/11443939
Liapina LA, Pastorova VE, Obergan TIu, Samonina GE, Ashmarin IP, Miasoedov NF. Comparison of anticoagulant effects of regulatory proline-containing oligopeptides: specificity of glyprolines, semax, and selank and potential of their practical application. Izv Akad Nauk Ser Biol. 2006;(2):193-203. In Russian; English abstract. pubmed.ncbi.nlm.nih.gov/16634437
Not Medical or Financial Advice
Selank is a registered medicine in Russia and an unapproved substance everywhere else. Treatment decisions belong with a qualified healthcare provider; anxiety has approved treatments with measured effects. Nothing on this page is a recommendation to buy or not to buy anything; it is an account of what determines what the money would be spent on.
Sources verified 16 September 2026. Re-verify before relying on anything here.